Pacira BioSciences, Inc.·4

Jun 13, 6:13 PM ET

HASTINGS PAUL J 4

4 · Pacira BioSciences, Inc. · Filed Jun 13, 2024

Insider Transaction Report

Form 4
Period: 2024-06-12
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-12+12,17912,179 total
    Exercise: $28.68From: 2025-06-12Exp: 2034-06-12Common Stock (12,179 underlying)
  • Award

    Common Stock

    2024-06-12+5,23013,604 total
  • Sale

    Common Stock

    2024-06-13$28.38/sh880$24,97412,724 total
Footnotes (2)
  • [F1]Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Documents

1 file
  • 4
    wk-form4_1718316771.xmlPrimary

    FORM 4